We are excited to share that as of today, Bristol Myers Squibb officially completed its acquisition of 2seventy bio. As one company, we look forward to continuing to deliver our CAR T cell therapy for multiple myeloma to patients who need it. Follow our progress Bristol Myers Squibb.
About us
2seventy bio is now part of Bristol Myers Squibb. Follow our progress in #CARTcelltherapy @Bristol Myers Squibb or www.bms.com.
- Website
-
http://www.bms.com
External link for 2seventy bio
- Industry
- Biotechnology
- Company size
- 51-200 employees
- Headquarters
- Cambridge, Massachusetts
- Type
- Public Company
- Specialties
- Cell therapy, oncology, gene therapy, cancer cell biology, and genetics
Locations
-
Primary
Get directions
Cambridge, Massachusetts, US